In March 2025, the company declared new programs to get a direct-to-purchaser supplying of its Wegovy weight loss drug. The company recognized a different pharmacy, referred to as NovoCare, which would cost consumers $499 every month for use of the drug, lower than fifty percent the expense of the drug through other pharmaceutical distribution netw